| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Inge Mertens | Q44363209 |
| Eline Oeyen | Q89491344 | ||
| Stefan De Wachter | Q91083477 | ||
| P2093 | author name string | Filip Ameye | |
| Marcella Baldewijns | |||
| Lucien Hoekx | |||
| P2860 | cites work | Identification and proteomic profiling of exosomes in human urine | Q24301829 |
| Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery | Q24305813 | ||
| Exosomes with immune modulatory features are present in human breast milk | Q24321270 | ||
| Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes | Q24604279 | ||
| ExoCarta 2012: database of exosomal proteins, RNA and lipids | Q24622676 | ||
| Critical evaluation of urinary markers for bladder cancer detection and monitoring | Q24654929 | ||
| Biomarkers for non-muscle invasive bladder cancer: Current tests and future promise | Q26775990 | ||
| Urine metabolomics for kidney cancer detection and biomarker discovery | Q27013059 | ||
| Urothelial cells undergo epithelial-to-mesenchymal transition after exposure to muscle invasive bladder cancer exosomes | Q27309880 | ||
| Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers | Q42816764 | ||
| The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle-associated immune complexes | Q43240413 | ||
| Comparative predictive values of urinary cytology, urinary bladder cancer antigen, CYFRA 21-1 and NMP22 for evaluating symptomatic patients at risk for bladder cancer | Q43601047 | ||
| Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome | Q44585154 | ||
| miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome | Q45021809 | ||
| UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing | Q45374139 | ||
| Clinical experience with survivin as a biomarker for urothelial bladder cancer | Q45800588 | ||
| Evaluation of an Epigenetic Profile for the Detection of Bladder Cancer in Patients with Hematuria | Q46135720 | ||
| Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients | Q46275263 | ||
| Updating the MISEV minimal requirements for extracellular vesicle studies: building bridges to reproducibility. | Q46308335 | ||
| Rapid Isolation and Detection of Exosomes and Associated Biomarkers from Plasma | Q46486257 | ||
| Identification of a three miRNA signature as a novel potential prognostic biomarker in patients with bladder cancer | Q47151820 | ||
| Exodisc for Rapid, Size-Selective, and Efficient Isolation and Analysis of Nanoscale Extracellular Vesicles from Biological Samples | Q47244795 | ||
| Characterization of urinary extracellular vesicle proteins in muscle-invasive bladder cancer. | Q47327779 | ||
| Recent Developments in the Search for Urinary Biomarkers in Bladder Cancer | Q47411078 | ||
| mRNA, microRNA and lncRNA as novel bladder tumor markers. | Q49965050 | ||
| UBC® Rapid Test for detection of carcinoma in situ for bladder cancer. | Q51022257 | ||
| Stimulation of blood mononuclear cells with bacterial virulence factors leads to the release of pro-coagulant and pro-inflammatory microparticles. | Q53216740 | ||
| Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer. | Q53251771 | ||
| Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. | Q53349518 | ||
| Diagnostic values of urine CYFRA21-1, NMP22, UBC, and FDP for the detection of bladder cancer. | Q53362942 | ||
| Upregulation of the long noncoding RNA HOTAIR predicts recurrence in stage Ta/T1 bladder cancer. | Q54198749 | ||
| Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice | Q28066211 | ||
| Optical and non-optical methods for detection and characterization of microparticles and exosomes | Q28294385 | ||
| Cancer exosomes trigger fibroblast to myofibroblast differentiation | Q28299016 | ||
| Bladder cancer biomarker discovery using global metabolomic profiling of urine | Q28542873 | ||
| Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia | Q28588931 | ||
| CCL18 in a multiplex urine-based assay for the detection of bladder cancer | Q28729838 | ||
| Extracellular vesicles: exosomes, microvesicles, and friends | Q29618137 | ||
| An integrated double-filtration microfluidic device for isolation, enrichment and quantification of urinary extracellular vesicles for detection of bladder cancer | Q30358093 | ||
| Isolation and identification of potential urinary microparticle biomarkers of bladder cancer | Q30445880 | ||
| Clinical significance of TROP2 expression in colorectal cancer | Q33243832 | ||
| Exosome-like vesicles with dipeptidyl peptidase IV in human saliva | Q33339840 | ||
| Proteomics analysis of bladder cancer exosomes. | Q33540122 | ||
| Massively parallel sequencing of human urinary exosome/microvesicle RNA reveals a predominance of non-coding RNA. | Q33590048 | ||
| Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). | Q33641504 | ||
| MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma | Q33648610 | ||
| Prospective evaluation of anxiety, pain, and embarrassment associated with cystoscopy and urodynamic testing in clinical practice | Q33696632 | ||
| Exploring the role of paraoxonase-2 in bladder cancer: analyses performed on tissue samples, urines and cell cultures | Q33709890 | ||
| Confounding factors of ultrafiltration and protein analysis in extracellular vesicle research | Q33758864 | ||
| HA-HAase urine test. A sensitive and specific method for detecting bladder cancer and evaluating its grade | Q33851124 | ||
| Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles | Q34026858 | ||
| Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies | Q34035888 | ||
| Human urinary exosomes as innate immune effectors | Q34103485 | ||
| Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses | Q34174003 | ||
| Standardization of sample collection, isolation and analysis methods in extracellular vesicle research | Q34369038 | ||
| Isolation of biologically-active exosomes from human plasma | Q34659945 | ||
| Identification of potential bladder cancer markers in urine by abundant-protein depletion coupled with quantitative proteomics. | Q34696553 | ||
| Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis | Q34785719 | ||
| Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments | Q35093755 | ||
| Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner | Q35182740 | ||
| Bladder tumour antigen (BTA stat) test compared to the urine cytology in the diagnosis of bladder cancer: A meta-analysis | Q35190183 | ||
| Biological properties of extracellular vesicles and their physiological functions. | Q35611763 | ||
| Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer | Q35650689 | ||
| Value of urinary cytology in the diagnosis and management of urinary tract malignancies | Q35796503 | ||
| Urine BLCA-4 exerts potential role in detecting patients with bladder cancers: a pooled analysis of individual studies | Q35804925 | ||
| Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma | Q38862176 | ||
| Cytokeratin-19 fragment in the diagnosis of bladder carcinoma | Q38905837 | ||
| Bladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progression | Q39023529 | ||
| Human trophoblast-derived exosomal fibronectin induces pro-inflammatory IL-1β production by macrophages | Q39575333 | ||
| Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer. | Q39586577 | ||
| ImmunoCyt test compared to cytology in the diagnosis of bladder cancer: A meta-analysis | Q39653062 | ||
| Fibroblast growth factor receptor 3 mutation analysis on voided urine for surveillance of patients with low-grade non-muscle-invasive bladder cancer. | Q39881578 | ||
| Human tumor-derived exosomes down-modulate NKG2D expression. | Q39980589 | ||
| MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins. | Q40150208 | ||
| EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. | Q40314364 | ||
| The community-based morbidity of flexible cystoscopy | Q40656661 | ||
| A holistic comparative analysis of diagnostic tests for urothelial carcinoma: a study of Cxbladder Detect, UroVysion® FISH, NMP22® and cytology based on imputation of multiple datasets. | Q40952174 | ||
| Proteome Profiling of Urinary Exosomes Identifies Alpha 1-Antitrypsin and H2B1K as Diagnostic and Prognostic Biomarkers for Urothelial Carcinoma | Q41238990 | ||
| A new role for microRNAs, as ligands of Toll-like receptors | Q41295458 | ||
| High-speed centrifugation induces aggregation of extracellular vesicles | Q41603157 | ||
| Exosomes of invasive urothelial carcinoma cells are characterized by a specific miRNA expression signature | Q41709261 | ||
| The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling | Q41903415 | ||
| A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine. | Q54357139 | ||
| The FGFR3 mutation is related to favorable pT1 bladder cancer. | Q54548813 | ||
| Urinary extracellular vesicle biomarkers in urological cancers: From discovery towards clinical implementation | Q56002130 | ||
| Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers | Q58213020 | ||
| TROP2 expression as prognostic marker for gastric carcinoma | Q58217959 | ||
| TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity | Q58217966 | ||
| Get on the exosome bus with ALIX | Q58298795 | ||
| Urinary Markers in Bladder Cancer: An Update | Q58758892 | ||
| Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | Q60142201 | ||
| Initial evaluation of the new urinary bladder cancer rapid test in the detection of transitional cell carcinoma of the bladder | Q73052185 | ||
| Tumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer | Q73099152 | ||
| Urine detection of survivin and diagnosis of bladder cancer | Q73437308 | ||
| Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4 | Q74067122 | ||
| Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer | Q77576308 | ||
| Diagnostic Utility of the ImmunoCyt/uCyt+ Test in Bladder Cancer | Q79456680 | ||
| Systemic induction of the angiogenesis switch by the tetraspanin D6.1A/CO-029 | Q79929804 | ||
| CD24 is a marker of exosomes secreted into urine and amniotic fluid | Q80799629 | ||
| Detection of bladder cancer using a point-of-care proteomic assay | Q81406362 | ||
| Use of the novel marker BLCA-1 for the detection of bladder cancer | Q81833168 | ||
| Circulating extracellular vesicles in cancer diagnosis and monitoring: an appraisal of clinical potential | Q86886262 | ||
| The diagnostic value of TROP-2, SLP-2 and CD56 expression in papillary thyroid carcinoma | Q89304937 | ||
| Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors | Q35842206 | ||
| Isolation of Exosomes from Blood Plasma: Qualitative and Quantitative Comparison of Ultracentrifugation and Size Exclusion Chromatography Methods | Q35874405 | ||
| Expression of the Long Non-Coding RNA HOTAIR Correlates with Disease Progression in Bladder Cancer and Is Contained in Bladder Cancer Patient Urinary Exosomes | Q35901823 | ||
| Highly sensitive and specific novel biomarkers for the diagnosis of transitional bladder carcinoma | Q35955378 | ||
| Exosomes and the kidney: prospects for diagnosis and therapy of renal diseases | Q36141289 | ||
| Prospects for urinary proteomics: exosomes as a source of urinary biomarkers | Q36164076 | ||
| Exosomes and immune surveillance of neoplastic lesions: a review | Q36241867 | ||
| MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer. | Q36294474 | ||
| Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classification | Q36331875 | ||
| A non-invasive miRNA based assay to detect bladder cancer in cell-free urine | Q36420310 | ||
| Urinary BTA: indicator of bladder cancer or of hematuria | Q36509699 | ||
| Molecular markers in bladder cancer: a critical appraisal | Q36526271 | ||
| Aneuploidy in bladder cancers: the utility of fluorescent in situ hybridization in clinical practice | Q36532210 | ||
| High expression of TROP2 correlates with poor prognosis in pancreatic cancer. | Q36944033 | ||
| Survivin: a promising biomarker for detection and prognosis of bladder cancer | Q36982448 | ||
| Photodynamic diagnosis in urology: state-of-the-art | Q37039163 | ||
| Proteomics analysis of vesicles isolated from plasma and urine of prostate cancer patients using a multiplex, aptamer-based protein array. | Q37057070 | ||
| Evaluation of urovysion and cytology for bladder cancer detection: a study of 1835 paired urine samples with clinical and histologic correlation | Q37238810 | ||
| Bladder cancer detection using FISH (UroVysion assay). | Q37250944 | ||
| Identification of extracellular vesicle-borne periostin as a feature of muscle-invasive bladder cancer | Q37269014 | ||
| Diagnosis of urothelial carcinoma from urine | Q37507532 | ||
| Trop2: a possible therapeutic target for late stage epithelial carcinomas | Q37580462 | ||
| Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer | Q37677090 | ||
| A Pilot Study on the Potential of RNA-Associated to Urinary Vesicles as a Suitable Non-Invasive Source for Diagnostic Purposes in Bladder Cancer. | Q37693488 | ||
| Exosome secretion: molecular mechanisms and roles in immune responses | Q37885448 | ||
| Recent advances on the role of tumor exosomes in immunosuppression and disease progression | Q37988647 | ||
| Epidemiology and risk factors of urothelial bladder cancer | Q38033265 | ||
| DNA methylation-based biomarkers in bladder cancer | Q38102879 | ||
| Potential of cancer cell-derived exosomes in clinical application: a review of recent research advances | Q38215089 | ||
| The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance | Q38216639 | ||
| miRNA panels as biomarkers for bladder cancer. | Q38239829 | ||
| The emerging role of extracellular vesicles as biomarkers for urogenital cancers. | Q38268801 | ||
| Urinary Biomarkers for Diagnosis of Bladder Cancer: A Systematic Review and Meta-analysis | Q38616474 | ||
| Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression | Q38740376 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | urine | Q40924 |
| bladder cancer | Q504775 | ||
| extracellular vesicle | Q21097485 | ||
| bladder neoplasm | Q55949884 | ||
| Extracellular vesicles | Q58039410 | ||
| cancer diagnosis | Q110324059 | ||
| P304 | page(s) | 821 | |
| P577 | publication date | 2019-02-14 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Bladder Cancer Diagnosis and Follow-Up: The Current Status and Possible Role of Extracellular Vesicles | |
| P478 | volume | 20 |
| Q89817510 | A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade |
| Q97565848 | Androgen deprivation therapy for prostate cancer and the risk of bladder cancer: A systematic review of observational studies |
| Q92835193 | Diagnostic accuracy of urinary survivin mRNA expression detected by RT-PCR compared with urine cytology in the detection of bladder cancer: A meta-analysis of diagnostic test accuracy in head-to-head studies |
| Q101564383 | Patient-derived tumour models for personalized therapeutics in urological cancers |
| Q92164090 | Sequential phosphoproteomics and N-glycoproteomics of plasma-derived extracellular vesicles |
| Q91711358 | Urine Biopsy-Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer |
Search more.